PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
- Research and development, 2025
- $159M
- YoY, 2025
- +15.3%
- 5-year CAGR
- +16.4%
- 10-year CAGR
- +29.7%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $159M | +15.3% |
| 2024 | $138M | +15.0% |
| 2023 | $120M | −4.8% |
| 2022 | $126M | +0.2% |
| 2021 | $126M | +69.1% |
| 2020 | $75M | +14.6% |
| 2019 | $65M | +9.3% |
| 2018 | $59M | +28.8% |
| 2017 | $46M | +79.7% |
| 2016 | $26M | +117.3% |
| 2015 | $12M | +58.6% |
| 2014 | $7.5M | — |